AQR Arbitrage’s Spark Therapeutics ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-857,478
Closed -$83.2M – 503
2019
Q3
$83.2M Buy
857,478
+131,309
+18% +$13.1M 1.22% 21
2019
Q2
$74.3M Sell
726,169
-62,824
-8% -$6.78M 0.85% 31
2019
Q1
$89.9M Buy
+788,993
New +$58M 1.13% 25

AQR Arbitrage's ONCE Position: Q4 2019 in Review

AQR Arbitrage sold out of Spark Therapeutics (ONCE) in Q4 2019, closing a stake of 857,478 shares — an estimated $83.2M sold.

AQR Arbitrage first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $89.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • AQR Arbitrage reported no remaining Spark Therapeutics position as of Q4 2019 after selling out during the quarter.
  • AQR Arbitrage sold 857,478 Spark Therapeutics shares in Q4 2019, an estimated $83.2M.
  • AQR Arbitrage first reported a position in Spark Therapeutics in Q1 2019 and held it in 3 quarters.
  • AQR Arbitrage's Spark Therapeutics position peaked at $89.9M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics as of Q4 2019.

Based on AQR Arbitrage's 13F filing for Q4 2019, filed 14 Feb 2020.